Decreased NCOR2 expression is correlated with increased disease aggressiveness in prostate cancer. Knocking down NCOR2 in cell line models induces the gene signature associated with neuroendocrine prostate cancer (NEPC). Here, NCOR2 is linked to prostate carcinoma.